Novartis India has reported results for the second quarter ended September 30, 2013.
The company has reported a rise of 15.79% in its net profit of Rs 45.55 crore for the quarter as compared to Rs 39.34 crore for the same quarter in the previous year. However, total income from operation of the company has decreased by 9.90% at Rs 213.92 crore for quarter under review as compared to Rs 237.43 crore for the quarter ended September 30, 2012.
Novartis India is engaged in manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare.
| Company Name | CMP |
|---|---|
| Redington | 222.80 |
| Adani Enterprises | 2505.65 |
| Amrapali Industries | 18.21 |
| Rashi Peripheral | 530.50 |
| PDS | 300.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: